Evidence map›Paper›PMID 31651402›Full record

ArticleJMIR mHealth and uHealth2019

A Mobile Health App (Roadmap 2.0) for Patients Undergoing Hematopoietic Stem Cell Transplant: Qualitative Study on Family Caregivers' Perspectives and Design Considerations.

Dima Chaar, Ji Youn Shin, Amanda Mazzoli, Rebecca Vue, Jacob Kedroske, Grant Chappell, David A Hanauer, Debra Barton, Afton L Hassett, Sung Won Choi

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JMIR mHealth and uHealth, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06991673 (Adolescent Surgery Roadmap Feasibility and Acceptability Study), which is not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
10.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06991673 naenrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Adolescent Surgery Roadmap Feasibility and Acceptability Study

TypeinterventionalSponsorUniversity of MichiganRan2025 to 2029Enrolled100ConditionsPediatric Surgical ProceduresArmsBehavioral Treatment
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Dima ChaarUniversity of Michigan, School of Public Health, Department of Epidemiology, Ann Arbor, MI, United States.ORCID 0000-0001-6755-0179
Ji Youn ShinMichigan State University, College of Communication Arts and Sciences, Department of Media and Information, East Lansing, MI, United States.ORCID 0000-0003-4978-3897
Amanda MazzoliUniversity of Michigan, Medical School, Blood and Marrow Transplantation Program, Ann Arbor, MI, United States.ORCID 0000-0001-6625-3092
Rebecca VueUniversity of Michigan, Medical School, Blood and Marrow Transplantation Program, Ann Arbor, MI, United States.ORCID 0000-0002-1414-7164
Jacob KedroskeUniversity of Michigan, Medical School, Blood and Marrow Transplantation Program, Ann Arbor, MI, United States.ORCID 0000-0003-3414-2253
Grant ChappellUniversity of Michigan, Medical School, Blood and Marrow Transplantation Program, Ann Arbor, MI, United States.ORCID 0000-0001-7236-5402
David A HanauerUniversity of Michigan, Medical School, Michigan Institute for Clinical and Health Research, Ann Arbor, MI, United States.ORCID 0000-0001-6931-3791
Debra BartonUniversity of Michigan, School of Nursing, Ann Arbor, MI, United States.ORCID 0000-0001-6624-3476
Afton L HassettUniversity of Michigan, Medical School, Department of Anesthesiology, Ann Arbor, MI, United States.ORCID 0000-0003-2982-484X
Sung Won ChoiUniversity of Michigan, Medical School, Blood and Marrow Transplantation Program, Ann Arbor, MI, United States.ORCID 0000-0002-6321-3834
University of Michigan · USMichigan State University · US

Funding

Roadmap 2.0: A randomized controlled trial using a technology-mediated platform in family caregivers of BMT patientsR01HL146354 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHOI, SUNG WON · 2019 to 2023
$1.8M
NHLBI NIH HHS R01 HL146354
6 · The paper itself

Abstract

backgroundHematopoietic stem cell transplantation (HCT), also referred to as blood and marrow transplantation (BMT), is a high-risk, but potentially curative therapy for a number of cancer and noncancer conditions. BMT Roadmap (Roadmap 1.0) is a mobile health app that was developed as a family caregiver-facing tool to provide informational needs about the health status of patients undergoing inpatient HCT.

objectiveThis study explored the views and perceptions of family caregivers of patients undergoing HCT and their input regarding further technology development and expansion of BMT Roadmap into the outpatient setting (referred to as Roadmap 2.0).

methodsSemistructured qualitative interviews were conducted among 24 family caregivers. Questions were developed from existing literature coupled with prior in-depth observations and interviews in hospital-based settings to explore the study objectives. Participants were recruited during routine outpatient clinic appointments of HCT patients, and all interviews were conducted in the participants' homes, the setting in which Roadmap 2.0 is intended for use. A thematic analysis was performed using a consistent set of codes derived from our prior research. New emerging codes were also included, and the coding structure was refined with iterative cycles of coding and data collection.

resultsFour major themes emerged through our qualitative analysis: (1) stress related to balancing caregiving duties; (2) learning and adapting to new routines (resilience); (3) balancing one's own needs with the patient's needs (insight); and (4) benefits of caregiving. When caregivers were further probed about their views on engagement with positive activity interventions (ie, pleasant activities that promote positive emotions and well-being such as expressing gratitude or engaging in activities that promote positive thoughts, emotions, and behaviors), they preferred a "menu" of positive activities to help support caregiver health and well-being.

conclusionsThis study involved family caregivers as participants in the development of new components for Roadmap 2.0. Our research provided a further understanding of the many priorities that hematopoietic stem cell transplant family caregivers face while maintaining balance in their lives. Their schedules can often be unpredictable, even more so once the patient is discharged from the hospital. Our findings suggest that expanding Roadmap 2.0 into the outpatient setting may provide critical caregiver support and that HCT caregivers are interested in and willing to engage in positive activities that may enhance well-being and attenuate the stress associated with caregiving. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/resprot.4918.

Indexed as

AdultCaregiversEquipment DesignFemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedMobile ApplicationsQualitative Researchallogeneic hematopoietic stem cell transplantcaregivershome interviewsmobile health appsuser experience

Identifiers

PMID31651402
PMCPMC6913725
OpenAlexW2975155518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.